News

Gladstone in the News November 26, 2021

Experts Peg Omicron as “Worst Variant That We Have Come Across”; Here’s What They Know So Far

ABC News—A new variant of SARS-CoV-2, dubbed Omicron, is causing concern around the world. Gladstone President Deepak Srivastava explains that some of the variant’s 50 mutations may have arisen when an individual who was already immunocompromised became infected with the virus. Senior Investigator Nevan Krogan describes how his group is investigating whether the new mutations will change the ability of the virus to enter cells and cause disease.

Gladstone Experts COVID-19 Data Science and Biotechnology Infectious Disease Krogan Lab Srivastava Lab

Gladstone in the News October 12, 2021

New COVID-19 Pill Is Not a Substitute for the Vaccine, According to Experts—Here’s Why

ABC7 News—Gladstone President Deepak Srivastava, MD, and Senior Investigator Nevan Krogan, PhD, compare and contrast vaccines to Merck’s new drug against COVID-19.

Gladstone Experts COVID-19 Cardiovascular Disease Data Science and Biotechnology Krogan Lab Srivastava Lab

Gladstone in the News July 6, 2021

Study Suggests Children Are Breathing CO2 When Wearing Masks, Experts Say Levels Are Not Dangerous

ABC7 News—A new study shows that wearing a mask increases slightly the amount of carbon dioxide children breathe. Gladstone President Deepak Srivastava, MD, cautions that the study was small, the increase in carbon dioxide is not known to be dangerous, and that wearing a mask and getting vaccinated remain the best protections against COVID-19.

COVID-19 Cardiovascular Disease Srivastava Lab

Article June 23, 2021

Flipping a Molecular Switch for Heart Fibrosis

Gladstone researchers discover how to reverse cardiac scarring—and how this could treat heart failure

News Release Research (Publication) Heart Failure Cardiovascular Disease Alexanian Lab Srivastava Lab CRISPR/Gene Editing

Gladstone in the News April 19, 2021

Worried about Your J&J COVID-19 Vaccine as Shots Are Paused? Don’t Be, Experts Say.

abc News—Gladstone Institutes President Deepak Srivastava, MD, describes possible symptoms of blood clots after vaccination with the Johnson & Johnson vaccine, but reiterates that such side effects are extremely rare and should not be a reason for alarm for the millions of people who have already received their J&J shot.

COVID-19 Srivastava Lab

Gladstone in the News February 3, 2021

San Francisco Researchers Use Genetic Clues to Identify Possible Drug for Treating Heart Conditions

ABC7 News—Gladstone President Deepak Srivastava, MD, a pediatric cardiologist, explains how his group discovered a potential new drug to treat a debilitating disease due to the hardening of heart valves.

Gladstone Experts Congenital Heart Disease Cardiovascular Disease Srivastava Lab Stem Cells/iPSCs

Article December 10, 2020

A Potential Therapy for One of the Leading Causes of Heart Disease

A drug candidate found by Gladstone researchers could help prevent tens of thousands of heart surgeries every year

News Release Research (Publication) Heart Failure Cardiovascular Disease Srivastava Lab Theodoris Lab AI CRISPR/Gene Editing Disease Models Stem Cells/iPSCs

Gladstone in the News November 1, 2020

California Prop 14 May Change Lives of Sick Kids, Keep Taxpayer Funding of Stem Cell Therapy Research

USA Today—California Proposition 14 put funding for the Stem Cell Research Institute on the ballot this year. Gladstone President Deepak Srivastava, MD, explains how previous funding for stem cell research in California has helped bring the field to a point where stem cell–based therapies are now possible.

Gladstone Experts Cardiovascular Disease Srivastava Lab Stem Cells/iPSCs

Gladstone in the News October 18, 2020

Conservatives Confront Moral Dilemma of Vaccines and Treatments Derived from Fetal Tissue Cells

abc News—In 2019, the Trump administration suspended federal funding for research involving fetal tissue. Gladstone President Deepak Srivastava explains that if the funding ban had been in place over the last few decades, many important drugs—including treatments for COVID-19—would not have been developed.

Gladstone Experts COVID-19 Roddenberry Stem Cell Center Srivastava Lab Stem Cells/iPSCs

Gladstone in the News October 14, 2020

Trump’s COVID-19 Treatment Developed Using Cells Originally Drawn from Fetal Tissue

abc News—Gladstone President Deepak Srivastava, MD, comments on the fact that the experimental treatments President Trump received for COVID-19 were tested on cells that were derived from fetal tissue decades ago, and expresses concern that the Trump administration’s current ban on the use of fetal tissue for research could slow efforts to curb the pandemic.

Gladstone Experts COVID-19 Cardiovascular Disease Srivastava Lab

Gladstone in the News October 8, 2020

Trump’s Covid Treatments Were Tested in Cells Derived From Fetal Tissue

The New York Times—The experimental drugs used to treat President Trump for COVID-19 were developed with the help of a human cell line derived from a fetus aborted decades ago. Gladstone President Deepak Srivastava, MD, and Senior Investigator Warner Greene, MD, PhD, comment on the ethics of accepting this treatment while also banning research using newly derived fetal cells, in the process thwarting the development of life-saving treatments for other conditions.

Gladstone Experts COVID-19 Cardiovascular Disease Center for HIV Cure Research Greene Lab Srivastava Lab

Gladstone in the News October 6, 2020

Doudna Inc.: How Cal Scientist Created a Biotech Startup Engine

San Francisco Business Times—As Scribe Therapeutics Inc., the latest company founded by Senior Investigator Jennifer Doudna, PhD, announced that it landed a deal with Biogen Inc., Gladstone President Deepak Srivastava, MD, commented on the importance of CRISPR-based biotech companies for medicine and agriculture and on Doudna’s drive as a scientist.

Gladstone Experts Cardiovascular Disease Data Science and Biotechnology Doudna Lab Srivastava Lab CRISPR/Gene Editing

Gladstone in the News September 4, 2020

Bay Area Researchers Explain “Concerning” Effects of COVID-19 on Human Hearts

ABC7 News—As sports teams and colleges consider restarting the athletics season, Senior Investigator Todd McDevitt, PhD, and Gladstone President and Cardiologist Deepak Srivastava, MD, express concern that damage to the heart caused by SARS-CoV-2 infection could put athletes at risk for serious heart problems even if they only experienced mild COVID-19 symptoms.

Gladstone Experts COVID-19 Cardiovascular Disease McDevitt Lab Srivastava Lab

Gladstone in the News June 27, 2020

A ‘Cure for Heart Disease’? A Single Shot Succeeds in Monkeys

The New York Times—Gladstone President Deepak Srivastava, MD, and Senior Investigator Jennifer Doudna, PhD, comment on a recent report of the successful use of novel CRISPR technology to lower cholesterol and triglyceride levels in monkeys.

Gladstone Experts Heart Failure Cardiovascular Disease Data Science and Biotechnology Doudna Lab Srivastava Lab CRISPR/Gene Editing Disease Models

Article May 8, 2020

Roddenberry Foundation Donates $1 Million to Support Gladstone COVID-19 Research

This generous gift will support Gladstone scientists who are pivoting their ongoing work to help fight the COVID-19 pandemic.

Donor Stories COVID-19 Roddenberry Stem Cell Center Srivastava Lab